France Allows Wider Pharmacy Substitution of Biosimilar and Hybrid Medicines
New Health Ministry rules allow pharmacists to replace prescribed reference medicines with approved biosimilar or hybrid alternatives unless physicians specifically prohibit substitution, with reimbursement restrictions applying when patients refuse alternatives without medical justification.